The cancer gene therapy market is poised to grow by USD 2.96 billion during 2021-2025 progressing at a CAGR of over 20% during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005646/en/
Technavio has announced its latest market research report titled Global Cancer Gene Therapy Market 2021-2025 (Graphic: Business Wire)
Worried about the impact of COVID-19 on your business? Here is an exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the cancer gene therapy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the side effects of traditional cancer treatments.
The cancer gene therapy market analysis includes the application and geography landscape. This study identifies the partnerships and collaborations that are changing the market scenario as one of the prime reasons driving the cancer gene therapy market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The cancer gene therapy market covers the following areas:
Cancer Gene Therapy Market Sizing
Cancer Gene Therapy Market Forecast
Cancer Gene Therapy Market Analysis
Companies Mentioned
- Adaptimmune Therapeutics plc
- Advantagene Inc.
- Amgen Inc.
- Anchiano Therapeutics Ltd.
- bluebird bio Inc.
- GlaxoSmithKline Plc
- Merck KGaA
- Shanghai Sunway Biotech Co. Ltd.
- Sibiono GeneTech Co. Ltd. Shenzhen (Sibiono)
- ZIOPHARM Oncology Inc.
Related Reports on Health Care Include:
Global Parkinsons Disease (PD) Drugs Market- The Parkinson's disease (PD) drugs market is segmented by drug class (DA and levodopa-carbidopa, MAO inhibitors, AChE inhibitors, glutamate inhibitors, and others), geography (Asia, Europe, North America, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report
Global Hepatitis C Drugs Market- The hepatitis C drug market is segmented by product (combination therapy and monotherapy), geography (Asia, Europe, North America, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Therapy
- Market segments
- Comparison by Therapy
- Oncolytic virotherapy - Market size and forecast 2020-2025
- Gene transfer - Market size and forecast 2020-2025
- Gene-induced immunotherapy - Market size and forecast 2020-2025
- Market opportunity by Therapy
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Volume drivers – Demand led growth
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Adaptimmune Therapeutics plc
- Advantagene Inc.
- Amgen Inc.
- Anchiano Therapeutics Ltd.
- bluebird bio Inc.
- GlaxoSmithKline Plc
- Merck KGaA
- Shanghai Sunway Biotech Co. Ltd.
- Sibiono GeneTech Co. Ltd. Shenzhen (Sibiono)
- ZIOPHARM Oncology Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210121005646/en/
